Top compounds associated with response to RP11-463D19.2


Feature Type Standardized
Nominal ANOVA
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0004
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA PX-12 CTRPv2 pan-cancer AAC 0.1 0.0005
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA indisulam CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BRD-K14844214 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.17 0.002
Download CSV